Filing Flows › Neuraxis (NRXS) › Q1 2026 › vs Q1 2025
Neuraxis (NRXS) Q1 2026 vs Q1 2025 (year over year)
Neuraxis's revenue rose $712K (+80%) from $896K in Q1 2025 to $1.6M in Q1 2026.
Neuraxis, Q1 2026: revenue $1.6M (+80% year over year), operating margin -108.3%, net loss $1.8M, operating cash flow −$1.2M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.6M | $896K | $712K | +80% |
| Net loss | $1.8M | $2.3M | −$517K | -23% |
| Costs & expenses | $3.4M | $3.2M | $179K | +6% |
| Operating costs | $3.3M | $3.2M | $158K | +5% |
| Interest & other, net | $21K | −$16K | $37K | — |
| Cost of revenue | $218K | $139K | $79K | +57% |
| Research & development | $100K | $118K | −$18K | -16% |
| Sales & marketing | $824K | $500K | $324K | +65% |
| General & admin | $2.2M | $2.4M | −$227K | -9% |
| Operating cash sources | $1.8M | $2.3M | −$517K | -23% |
| Depreciation & amortization | $16K | $6K | $10K | +157% |
| Share-based compensation | $329K | $106K | $224K | +211% |
| Working capital & other | $186K | $563K | −$377K | -67% |
| Cash used in operations | $1.2M | $1.6M | −$374K | -23% |
| Net loss absorbed | $1.8M | $2.3M | −$517K | -23% |
Questions
How much did Neuraxis's revenue grow year over year in Q1 2026?
Neuraxis's revenue rose $712K (+80%) from $896K in Q1 2025 to $1.6M in Q1 2026.